CVRx (CVRX) Stock Forecast, Price Target & Predictions
CVRX Stock Forecast
CVRx stock forecast is as follows: an average price target of $14.25 (represents a 21.48% upside from CVRX’s last price of $11.73) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.
CVRX Price Target
CVRX Analyst Ratings
Buy
CVRx Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Oct 30, 2024 | Matt O'Brien | Piper Sandler | $16.00 | $12.90 | 23.99% | 36.40% |
Sep 10, 2024 | Ross Osborn | Cantor Fitzgerald | $14.00 | $7.96 | 75.88% | 19.35% |
Jul 30, 2024 | Matt O'Brien | Piper Sandler | $13.00 | $9.27 | 40.24% | 10.83% |
Jul 30, 2024 | William Plovanic | Canaccord Genuity | $15.00 | $9.27 | 61.81% | 27.88% |
Jul 11, 2024 | Frank Takkinen | Lake Street | $12.00 | $7.59 | 58.10% | 2.30% |
Jun 05, 2024 | Frank Takkinen | Loop Capital Markets | $18.00 | $8.00 | 125.14% | 53.45% |
May 01, 2024 | Chase Knickerbocker | Craig-Hallum | $23.00 | $9.27 | 148.11% | 96.08% |
CVRx Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 1 | 7 |
Avg Price Target | - | $16.00 | $15.86 |
Last Closing Price | $11.73 | $11.73 | $11.73 |
Upside/Downside | -100.00% | 36.40% | 35.21% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 30, 2024 | Lake Street | Buy | Buy | Hold |
Oct 30, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Oct 23, 2024 | Lake Street | Underperform | Underperform | Hold |
Oct 23, 2024 | Piper Sandler | Buy | Buy | Hold |
Oct 21, 2024 | Cantor Fitzgerald | Overweight | Overweight | Hold |
Oct 21, 2024 | Canaccord Genuity | Buy | Buy | Hold |
Sep 10, 2024 | Cantor Fitzgerald | Overweight | Initialise | |
Aug 26, 2024 | Piper Sandler | Buy | Buy | Hold |
Jul 30, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Jul 30, 2024 | Canaccord Genuity | Buy | Buy | Hold |
Jul 11, 2024 | Lake Street | Buy | Buy | Hold |
Jun 05, 2024 | Lake Street | Buy | Buy | Hold |
May 01, 2024 | William Blair | Market Perform | Downgrade | |
Dec 27, 2023 | Lake Street | Buy | Buy | Hold |
Feb 07, 2023 | Canaccord Genuity | Buy | Buy | Hold |
Jan 09, 2023 | Piper Sandler | Overweight | Overweight | Hold |
Apr 26, 2022 | Zacks Investment Research | Hold | Upgrade |
CVRx Financial Forecast
CVRx Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $10.51M | $9.50M | $7.98M | $7.18M | $6.19M | $5.03M | $4.08M | $3.66M | $3.40M | $3.12M |
Avg Forecast | $21.85M | $20.64M | $19.72M | $17.38M | $17.53M | $16.49M | $15.54M | $14.63M | $14.86M | $13.18M | $11.80M | $11.42M | $11.14M | $9.82M | $8.59M | $7.20M | $6.97M | $5.72M | $4.70M | $3.79M | $3.88M | $3.29M | $2.83M |
High Forecast | $22.32M | $21.07M | $20.14M | $17.75M | $17.90M | $16.84M | $15.87M | $14.73M | $15.06M | $13.18M | $11.80M | $11.42M | $11.38M | $10.10M | $8.77M | $7.35M | $7.12M | $5.72M | $4.70M | $3.79M | $3.88M | $3.29M | $2.83M |
Low Forecast | $21.38M | $20.19M | $19.29M | $17.00M | $17.14M | $16.13M | $15.20M | $14.53M | $14.55M | $13.18M | $11.80M | $11.42M | $10.90M | $9.50M | $8.40M | $7.04M | $6.82M | $5.72M | $4.70M | $3.79M | $3.88M | $3.29M | $2.83M |
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 2 | 1 | 1 | 1 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.07% | 1.11% | 1.11% | 1.03% | 1.08% | 1.07% | 1.08% | 0.94% | 1.03% | 1.10% |
Forecast
CVRx EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 2 | 1 | 1 | 1 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $-8.47M | $-11.14M | $-11.10M | $-10.34M | $-9.80M | $-11.05M | $-9.96M | $-10.09M | $-5.45M | $-17.08M |
Avg Forecast | $-21.79M | $-20.58M | $-19.67M | $-17.33M | $-17.48M | $-16.44M | $-15.49M | $-14.59M | $-14.81M | $-13.14M | $-11.76M | $-11.98M | $-11.11M | $-9.80M | $-8.56M | $-10.89M | $-8.78M | $-5.72M | $-4.70M | $-9.90M | $-3.88M | $-3.29M | $-9.45M |
High Forecast | $-21.31M | $-20.13M | $-19.24M | $-16.95M | $-17.09M | $-16.08M | $-15.15M | $-14.49M | $-14.51M | $-13.14M | $-11.76M | $-9.59M | $-10.87M | $-9.48M | $-8.37M | $-8.71M | $-7.02M | $-5.72M | $-4.70M | $-7.92M | $-3.88M | $-3.29M | $-7.56M |
Low Forecast | $-22.25M | $-21.01M | $-20.08M | $-17.70M | $-17.84M | $-16.79M | $-15.82M | $-14.69M | $-15.01M | $-13.15M | $-11.76M | $-14.38M | $-11.35M | $-10.08M | $-8.74M | $-13.07M | $-10.53M | $-5.72M | $-4.70M | $-11.88M | $-3.88M | $-3.29M | $-11.34M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.86% | 1.30% | 1.02% | 1.18% | 1.71% | 2.35% | 1.01% | 2.60% | 1.66% | 1.81% |
Forecast
CVRx Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 2 | 1 | 1 | 1 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $-9.01M | $-11.65M | $-11.37M | $-10.54M | $-9.83M | $-11.07M | $-9.99M | $-10.57M | $-6.13M | $-17.75M |
Avg Forecast | $-9.23M | $-10.31M | $-11.13M | $-13.98M | $-11.62M | $-11.81M | $-11.68M | $-11.78M | $-8.75M | $-11.48M | $-12.45M | $-12.09M | $-12.40M | $-13.18M | $-13.28M | $-10.99M | $-9.19M | $-11.84M | $-11.51M | $-9.99M | $-9.62M | $-8.27M | $-9.82M |
High Forecast | $-8.97M | $-10.02M | $-10.81M | $-13.58M | $-11.29M | $-11.48M | $-11.35M | $-8.67M | $-8.52M | $-11.16M | $-12.09M | $-9.67M | $-11.73M | $-12.27M | $-12.91M | $-8.79M | $-7.35M | $-11.84M | $-11.51M | $-7.99M | $-9.62M | $-8.27M | $-7.85M |
Low Forecast | $-9.49M | $-10.59M | $-11.44M | $-14.37M | $-11.94M | $-12.14M | $-12.01M | $-14.67M | $-8.98M | $-11.80M | $-12.79M | $-14.51M | $-12.86M | $-13.86M | $-13.65M | $-13.19M | $-11.03M | $-11.84M | $-11.51M | $-11.99M | $-9.62M | $-8.27M | $-11.78M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.68% | 0.88% | 1.03% | 1.15% | 0.83% | 0.96% | 1.00% | 1.10% | 0.74% | 1.81% |
Forecast
CVRx SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 2 | 1 | 1 | 1 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $15.65M | $16.45M | $15.40M | $14.10M | $12.68M | $12.49M | $10.78M | $9.66M | $8.11M | $5.63M |
Avg Forecast | $37.53M | $35.45M | $33.87M | $29.85M | $30.10M | $28.32M | $26.69M | $25.13M | $25.51M | $22.64M | $20.26M | $19.62M | $19.14M | $16.87M | $14.74M | $12.37M | $11.97M | $9.82M | $8.07M | $6.51M | $6.67M | $5.65M | $4.86M |
High Forecast | $38.33M | $36.20M | $34.59M | $30.48M | $30.74M | $28.92M | $27.25M | $25.30M | $25.86M | $22.64M | $20.26M | $19.62M | $19.54M | $17.36M | $15.06M | $12.63M | $12.23M | $9.82M | $8.07M | $6.51M | $6.67M | $5.65M | $4.86M |
Low Forecast | $36.71M | $34.67M | $33.13M | $29.20M | $29.44M | $27.70M | $26.10M | $24.96M | $25.00M | $22.63M | $20.26M | $19.62M | $18.72M | $16.32M | $14.42M | $12.10M | $11.71M | $9.82M | $8.07M | $6.51M | $6.67M | $5.65M | $4.86M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.93% | 1.12% | 1.25% | 1.18% | 1.29% | 1.55% | 1.66% | 1.45% | 1.44% | 1.16% |
Forecast
CVRx EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 2 | 1 | 1 | 1 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.43 | $-0.56 | $-0.55 | $-0.51 | $-0.48 | $-0.54 | $-0.49 | $-0.52 | $-0.30 | $-0.88 |
Avg Forecast | $-0.41 | $-0.45 | $-0.49 | $-0.61 | $-0.51 | $-0.52 | $-0.51 | $-0.52 | $-0.38 | $-0.50 | $-0.55 | $-0.54 | $-0.54 | $-0.58 | $-0.58 | $-0.57 | $-0.56 | $-0.55 | $-0.53 | $-0.49 | $-0.45 | $-0.38 | $-0.64 |
High Forecast | $-0.39 | $-0.44 | $-0.47 | $-0.60 | $-0.50 | $-0.50 | $-0.50 | $-0.38 | $-0.37 | $-0.49 | $-0.53 | $-0.53 | $-0.51 | $-0.54 | $-0.57 | $-0.55 | $-0.54 | $-0.55 | $-0.53 | $-0.49 | $-0.45 | $-0.38 | $-0.64 |
Low Forecast | $-0.42 | $-0.46 | $-0.50 | $-0.63 | $-0.52 | $-0.53 | $-0.53 | $-0.64 | $-0.39 | $-0.52 | $-0.56 | $-0.56 | $-0.56 | $-0.61 | $-0.60 | $-0.58 | $-0.57 | $-0.55 | $-0.53 | $-0.49 | $-0.45 | $-0.38 | $-0.64 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.74% | 0.96% | 0.97% | 0.92% | 0.88% | 1.02% | 1.00% | 1.17% | 0.78% | 1.38% |
Forecast
CVRx Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
LUNG | Pulmonx | $6.13 | $13.00 | 112.07% | Buy |
SGHT | Sight Sciences | $3.62 | $7.50 | 107.18% | Hold |
KIDS | OrthoPediatrics | $22.46 | $39.50 | 75.87% | Buy |
LIVN | LivaNova | $49.94 | $68.25 | 36.66% | Buy |
OFIX | Orthofix Medical | $17.93 | $24.00 | 33.85% | |
NPCE | NeuroPace | $11.52 | $15.00 | 30.21% | Buy |
CVRX | CVRx | $13.16 | $14.25 | 8.28% | Buy |
AORT | Artivion | $28.90 | $30.75 | 6.40% | Buy |
SRDX | Surmodics | $39.96 | $39.50 | -1.15% | Buy |